日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-Time Monitoring of the Formation and Culture of Hybrid Cell-Microbiomaterial Spheroids Using Non-Faradaic Electrical Impedance Spectroscopy

利用非法拉第电阻抗谱法实时监测混合细胞-微生物材料球体的形成和培养

Fois, Maria G; Bormans, Seppe; Vandenryt, Thijs; Guttenplan, Alexander P M; Alaoui Selsouli, Yousra; van Blitterswijk, Clemens; Tahmasebi Birgani, Zeinab; Giselbrecht, Stefan; Habibović, Pamela; Thoelen, Ronald; Truckenmüller, Roman K

Racial differences in real-world outcomes of first-line therapies for advanced renal cell carcinoma

晚期肾细胞癌一线治疗真实世界疗效中的种族差异

Geynisman, Daniel M; John, William S; Miller, Taavy A; Asgarisabet, Parisa; Guttenplan, Sarah B; Yin, Xin; Savill, Kristin M Zimmerman; McAllister, Lindsay; Rosenblatt, Lisa

Stretchable Porous Membranes for Barrier Tissue Models with Real-Time Measurement and Biomimetic Cyclic Strain

用于屏障组织模型的可拉伸多孔膜,具有实时测量和仿生循环应变功能

Guttenplan, Alexander P M; Robertson, Joseph W F; Reyes, Darwin R

Erratum: Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States

更正:美国一线接受纳武利尤单抗联合伊匹木单抗治疗的转移性肾细胞癌患者的真实世界结果

Doshi, Gurjyot K; Osterland, Andrew J; Shi, Ping; Yim, Annette; Del Tejo, Viviana; Guttenplan, Sarah B; Eiffert, Samantha; Yin, Xin; Rosenblatt, Lisa; Conkling, Paul R

Extravascular implantable cardioverter-defibrillator implantation in a patient with nickel and cobalt allergies

对镍和钴过敏的患者进行血管外植入式心脏复律除颤器植入术

Song, Justin J; Yang, Ronghua; Guttenplan, Nils A

An emergent disease-associated motor neuron state precedes cell death in a mouse model of ALS

在肌萎缩侧索硬化症(ALS)小鼠模型中,一种与疾病相关的运动神经元新状态先于细胞死亡出现。

Gautier, Olivia; Blum, Jacob A; Nguyen, Thao P; Klemm, Sandy; Yamakawa, Mai; Sinnott-Armstrong, Nasa; Zeng, Yi; Davis, Chung-Ha O; Bombosch, Juliane; Nakayama, Lisa; Guttenplan, Kevin A; Chen, Derek; Kathira, Arwa; Zhao, Luke; Rexach, Jessica E; Greenleaf, William J; Gitler, Aaron D

37 Cost-effectiveness of treatment sequences with front-line nivolumab+ipilimumab therapy vs immuno-oncology+tyrosine kinase inhibitor therapies in intermediate/poor-risk metastatic renal cell carcinoma

37. 中/高危转移性肾细胞癌一线治疗方案中,纳武利尤单抗+伊匹木单抗联合治疗与免疫肿瘤联合酪氨酸激酶抑制剂联合治疗的成本效益分析

Iqbal, Muhammad Javed; Javed, Zeeshan; Herrera-Bravo, Jesús; Sadia, Haleema; Anum, Faiza; Raza, Shahid; Tahir, Arifa; Shahwani, Muhammad Naeem; Sharifi-Rad, Javad; Calina, Daniela; Cho, William C; Ebrahimi, Hedyeh; Berardi, Andrea; Smare, Caitlin; Pavlidou, Eleni; Guttenplan, Sarah B; Eiffert, Sam; Rosenblatt, Lisa; Kurt, Murat; Yin, Xin; Chehrazi-Raffle, Alexander

Vesicle Fusion in Oligodendrocyte Maturation and Myelination

少突胶质细胞成熟和髓鞘形成过程中的囊泡融合

Hupp, Madison T; Santos, Erin N; Heo, Dongeun; Call, Cody L; Guttenplan, Kevin A

Long-Term Temporal Trends of Real-World Healthcare Costs Associated with Nivolumab Plus Ipilimumab and Pembrolizumab Plus Axitinib as First-Line Treatment for Advanced or Metastatic Renal Cell Carcinoma

纳武利尤单抗联合伊匹木单抗和帕博利珠单抗联合阿昔替尼作为晚期或转移性肾细胞癌一线治疗方案的真实世界医疗保健成本的长期时间趋势

Du, Ella Xiaoyan; Betts, Keith A; Wang, Travis; Kitchen, Sophie A; He, Xuanhao; Yin, Xin; Guttenplan, Sarah B; Beauchamp, Karen; Delgado, Andrew; Rosenblatt, Lisa

Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States

美国接受一线纳武利尤单抗联合伊匹木单抗治疗的转移性肾细胞癌患者的真实世界疗效

Doshi, Gurjyot K; Osterland, Andrew J; Shi, Ping; Yim, Annette; Del Tejo, Viviana; Guttenplan, Sarah B; Eiffert, Samantha; Yin, Xin; Rosenblatt, Lisa; Conkling, Paul R